Company profile
AtaiBeckley company profile
AtaiBeckley is a biopharmaceutical company that develops rapid-acting mental-health therapies. Its pipeline includes an intranasal mebufotenin benzoate candidate (BPL-003) for treatment-resistant depression, a DMT buccal film, and an oral R-MDMA compound . The company conducts clinical trials and drug development in neuropsychiatric conditions.
Business identity
- Website
- https://www.ataibeckley.com
- Contact email
- [email protected]
- Phone number
- +31 20 793 2536
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00051-00100 employees
- Revenue range
- $1K+
- Founded
- 2018-01-01
Headquarters
- Headquarters
- Brackenheim, Baden-Wurttemberg, Germany
- Postal code
- 10179
- Country code
- DE
- Continent
- Europe